Drug-resistant tuberculosis

Clinical trials for Drug-resistant tuberculosis explained in plain language.

Never miss a new study

Get alerted when new Drug-resistant tuberculosis trials appear

Sign up with your email to follow new studies for Drug-resistant tuberculosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 1 Completed 2

New hope for Drug-Resistant TB: a 6-Month pill regimen

Disease control Ongoing

This phase 3 trial is testing a 6-month, all-oral combination of four drugs (bedaquiline, delamanid, linezolid, and levofloxacin or clofazimine) to treat rifampin-resistant tuberculosis in Chinese teenagers and adults aged 12 and older. The goal is to see if this shorter regimen …

Matched conditions: DRUG-RESISTANT TUBERCULOSIS

Phase 3 • Sponsor: Huashan Hospital • Aim: Disease control

Last updated Jun 26, 2026 13:02 UTC

Drug-resistant tuberculosis

Get alerted when new Drug-resistant tuberculosis trials appear

New hope for Drug-Resistant TB: a 6-Month pill regimen